Dendrimer-nanoparticle (DEP) delivery of cabazitaxel (DEP-cabazitaxel): A first-in-human phase 1/2 trial in patients with advanced solid tumours
Robert H. Jones, David J. Pinato, Martin D. Forster, Anthony M. Joshua et autres
0 citationsEuropean Journal of Cancer